Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

Journal of Virology
Lee T BachelerC Rizzo

Abstract

Efavirenz (also known as DMP 266 or SUSTIVA) is a potent nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity and of HIV-1 replication in vitro and in vivo. Most patients on efavirenz-containing regimens have sustained antiviral responses; however, rebounds in plasma viral load have been observed in some patients in association with the emergence of mutant strains of HIV-1. Virus isolates from the peripheral blood mononuclear cells (PBMCs) of patients with such treatment failures, as well as recombinant viruses incorporating viral sequences derived from patient plasma, show reduced in vitro susceptibility to efavirenz in association with mutations in the RT gene encoding K103N, Y188L, or G190S/E substitutions. Patterns of RT gene mutations and in vitro susceptibility were similar in plasma virus and in viruses isolated from PBMCs. Variant strains of HIV-1 constructed by site-directed mutagenesis confirmed the role of K103N, G190S, and Y188L substitutions in reduced susceptibility to efavirenz. Further, certain secondary mutations (V106I, V108I, Y181C, Y188H, P225H, and F227L) conferred little resistance to efavirenz as single mutations but enhanced the level of resistance of...Continue Reading

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D RichmanJ Griffin
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·S J SmerdonT A Steitz
Jan 1, 1994·AIDS Research and Human Retroviruses·A M VandammeJ Anne
Feb 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S H CheesemanM Myers
Dec 30, 1994·Biochemical and Biophysical Research Communications·D L WinslowL T Bacheler
Sep 29, 1999·JAMA : the Journal of the American Medical Association·S J LittleD D Richman
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·L T BachelerK Abremski
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·J Martinez-PicadoR T D'Aquila

❮ Previous
Next ❯

Citations

Mar 12, 2004·International Journal of Antimicrobial Agents·M C ReUNKNOWN HIV-1 Emilia Romagna Infectious Disease Study Group
Oct 19, 2002·International Journal of Antimicrobial Agents·M C ReM La Placa
Oct 24, 2007·Journal of Chemical Information and Modeling·Gabriela BarreiroWilliam L Jorgensen
Dec 12, 2003·The New England Journal of Medicine·Robert W ShaferUNKNOWN AIDS Clinical Trials Group 384 Team
Oct 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hiroyu HatanoSteven G Deeks
Jun 14, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Aug 9, 2002·AIDS Research and Human Retroviruses·Jose L CasadoSantiago Moreno
Aug 30, 2007·AIDS Research and Human Retroviruses·Katyna Borroto-EsodaFrank S Rousseau
Mar 30, 2006·Biostatistics·Niko Beerenwinkel, Mathias Drton
May 14, 2010·The Journal of Antimicrobial Chemotherapy·Elizabeth C ReumanRobert W Shafer
Apr 5, 2012·Cold Spring Harbor Perspectives in Medicine·Eric J Arts, Daria J Hazuda
Jan 26, 2008·HIV Medicine·S LouvelUNKNOWN Swiss HIV Cohort Study
Jun 2, 2011·Antimicrobial Agents and Chemotherapy·Matthew D MarsdenJerome A Zack
Oct 29, 2008·Antimicrobial Agents and Chemotherapy·Fenglei HuangPatrick Robinson
Nov 11, 2009·Antimicrobial Agents and Chemotherapy·Anne-Genevieve MarcelinUNKNOWN ANRS AC11 Resistance Study Group
Dec 1, 2010·Antimicrobial Agents and Chemotherapy·Masanori KobayashiTamio Fujiwara
Mar 18, 2009·Antimicrobial Agents and Chemotherapy·Ming-Tain LaiMichael D Miller
Nov 30, 2011·Antimicrobial Agents and Chemotherapy·Susan M SchaderMark A Wainberg
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Robert G FerrisLawrence R Boone
Apr 5, 2002·Clinical Microbiology Reviews·Robert W Shafer
Dec 18, 2012·Journal of Clinical Microbiology·Moussa ThiamCoumba Toure-Kane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.